Janssen claims infringement of US patent over Laurus generic of HIV drug
MLex Summary: Janssen Sciences and Gilead Sciences filed a patent infringement suit in the District of New Jersey against Laurus Labs in opposition to Laurus’s Abbreviated New Drug Application (ANDA) to...To view the full article, register now.
Already a subscriber? Click here to view full article